AMF Medical Receives FDA Breakthrough Device Designation for Its Sigi™ Insulin Management System

ECUBLENS,Switzerland, Nov. 30, 2021 /PRNewswire/ --AMF Medical is proud to announce that its SigiInsulin Management System, for diabetes mellitus treatment, has met the criteria and has been granted Breakthrough Device Designation by the US Food and Drug Administration.